Search PDMR transactions

Notifier
Name
Erik Kinnman
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Erik Kinnman
Position
Styrelseledamot/suppleant
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Nasdaq First North
LEI
549300WD23DE1US21868
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 2,572 Quantity 12.41 SEK 15/07/2020 NASDAQ STOCKHOLM AB
Share STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 1,744 Quantity 12.41 SEK 14/07/2020 NASDAQ STOCKHOLM AB
Share STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 3,415 Quantity 12.41 SEK 16/07/2020 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 15/07/2020 NASDAQ STOCKHOLM AB 2,572 (Quantity) 12.41 SEK
STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 14/07/2020 NASDAQ STOCKHOLM AB 1,744 (Quantity) 12.41 SEK
STAYBLE THERAPEUTICS AB SE0013513652 Acquisition 16/07/2020 NASDAQ STOCKHOLM AB 3,415 (Quantity) 12.41 SEK
Total: 7,731
<< Back